Douglas Kerr
Director/Board Member bei Triplet Therapeutics, Inc.
Vermögen: 2 Mio $ am 31.03.2024
Profil
Douglas Kerr is currently a Director at Cure Sma, an Advisor at Atlas Venture Advisors, a Board Member at Triplet Therapeutics, and a Science Advisor at Exceptional Ventures LLP.
He previously worked as a Senior Director at Biogen, a Vice President at Shire Plc, an Associate Professor at The Johns Hopkins University School of Medicine, a Scientific Advisory Board Member at Disarm Therapeutics, and a Chief Medical Officer at Generation Bio Co. Kerr holds an MBA from Northeastern University, an undergraduate degree from Princeton University, and graduate and doctorate degrees from Sidney Kimmel Medical College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GENERATION BIO CO.
0,58% | 29.01.2024 | 385 628 ( 0,58% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Douglas Kerr
| Unternehmen | Position | Beginn |
|---|---|---|
Triplet Therapeutics, Inc.
 Triplet Therapeutics, Inc. Medical/Nursing ServicesHealth Services Triplet Therapeutics, Inc. develops therapy for huntington's , myotonic dystrophy, spin cerebellar ataxias and repeated expansion diseases. The company was founded by Jean-François Formela and Nessan Bermingham is headquartered in Cambridge, MA. | Director/Board Member | 01.07.2019 |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | - |
| Cure Sma | Director/Board Member | - |
Exceptional Ventures LLP
 Exceptional Ventures LLP Investment ManagersFinance Exceptional Ventures LLP (Exceptional Ventures) is a venture capital firm founded in 2022. The firm is headquartered in London, the United Kingdom. | Consultant / Advisor | 01.03.2022 |
Ehemalige bekannte Positionen von Douglas Kerr
| Unternehmen | Position | Ende |
|---|---|---|
| GENERATION BIO CO. | Chief Tech/Sci/R&D Officer | 28.01.2024 |
Faze Medicines, Inc. /MA)
 Faze Medicines, Inc. /MA) Miscellaneous Commercial ServicesCommercial Services Faze Medicines, Inc. provides medical services. The company is headquartered in San Francisco, CA. | Director/Board Member | 03.03.2023 |
Disarm Therapeutics, Inc.
 Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Consultant / Advisor | 30.11.2021 |
| SHIRE | Corporate Officer/Principal | - |
| BIOGEN INC. | Director/Board Member | 01.10.2015 |
Ausbildung von Douglas Kerr
| Northeastern University | Masters Business Admin |
| Princeton University | Undergraduate Degree |
| Sidney Kimmel Medical College | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| GENERATION BIO CO. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Health Technology |
Triplet Therapeutics, Inc.
Triplet Therapeutics, Inc. Medical/Nursing ServicesHealth Services Triplet Therapeutics, Inc. develops therapy for huntington's , myotonic dystrophy, spin cerebellar ataxias and repeated expansion diseases. The company was founded by Jean-François Formela and Nessan Bermingham is headquartered in Cambridge, MA. | Health Services |
| Cure Sma | |
Faze Medicines, Inc. /MA)
Faze Medicines, Inc. /MA) Miscellaneous Commercial ServicesCommercial Services Faze Medicines, Inc. provides medical services. The company is headquartered in San Francisco, CA. | Commercial Services |
Exceptional Ventures LLP
Exceptional Ventures LLP Investment ManagersFinance Exceptional Ventures LLP (Exceptional Ventures) is a venture capital firm founded in 2022. The firm is headquartered in London, the United Kingdom. | Finance |
